S. 1317 (109th): Stem Cell Therapeutic and Research Act of 2005


Jun 27, 2005
109th Congress, 2005–2006

Enacted as H.R. 2520 (companion bill)

Orrin Hatch

Senator from Utah



Read Text »
Last Updated: Jul 11, 2005
Length: 70 pages

See Instead:

H.R. 2520 (same title)
Enacted — Signed by the President — Dec 20, 2005

About the bill

Full Title

A bill to provide for the collection and maintenance of cord blood units for the treatment of patients and research, and to amend the Public Health Service Act to authorize the Bone Marrow and Cord Blood Cell Transplantation Program to increase the number of transplants for recipients suitable matched to donors of bone marrow and cord blood.

Summary (CRS)

7/11/2005--Reported to Senate amended.Stem Cell Therapeutic and Research Act of 2005 - Section2 - Requires the Secretary of Health and Human Services to contract with qualified cord blood stem cell ... Read more >

The bill’s title was written by its sponsor.


Jun 27, 2005

This is the first step in the legislative process.

Jun 29, 2005
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 1317”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


34 cosponsors (21R, 12D, 1I) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: